Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Clinical Trials
Mouse Study: Xenon Gas Prevents Cognitive Damage After Traumatic Brain Injury
‘Young Blood’ Researchers Are Still in the Pursuit to Stall Aging, Slow Alzheimer’s
Researchers To Test New Alzheimer’s Drug Targeting Inflammation in Humans
You Asked, We Got the Answers: Disruptive Alzheimer’s Behavior, Confusing Diagnoses, Supplements and Clinical Trials
‘There Was So Much Hope’: Biogen Trial Participants Are ‘Heartbroken’ After Cancellation
A Late-Stage Alzheimer’s Trial Gave Them Hope—Until It Was Canceled
Dementia Deaths Have More Than Doubled, According to Report. Here’s What Can Be Done
Alzheimer’s Prevention Gene Therapy to Be Tested in Humans
F.D.A. Gives Warning for Young Blood Treatment for Aging and Alzheimer’s
An Inexpensive HIV Drug Has Potential for Alzheimer’s
A Vaccine for Alzheimer’s Shows Promise in Human Trial
Will We Ever Find an Alzheimer’s Cure? The Answer Depends on Research Participants
New Evidence That Diabetes Drugs Could Help Alzheimer’s Patients, Too
Is Biogen and Eisai’s BAN2401 the Alzheimer’s Drug We’ve Been Waiting For?
Our Hope—And Questions—About Biogen and Eisai’s Latest Alzheimer’s Drug Trial Results
Previous
9
10
11
Next
Page load link
Go to Top